BIOMAT Database Logo BIOMAT Database Logo

Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. 1990

T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Department of Neurology, Karolinska Institutet, Huddinge University Hospital, Sweden.

Multiple sclerosis (MS) is a disease with unknown cause characterized by inflammation and demyelination in the central nervous system. Although an autoimmune pathogenesis has been suggested, there are no conclusive data on the number of T cells autoreactive with myelin antigens in MS compared to controls. We showed that T lymphocytes secreting interferon-gamma in response to possible target autoantigens are severalfold more common among PBL mononuclear cells in patients with MS than in patients with aseptic meningitis and tension headache. On average T cells reactive with myelin basic protein (MBP), two different MBP peptides, or with proteolipid protein amounted to 2.7-5.2/10(5) PBL from MS patients. MBP-reactive T cells were still more frequent among mononuclear cells isolated from the cerebrospinal fluid (CSF; 185/10(5) CSF cells). We concluded that T cells reactive with myelin autoantigens are strongly increased in MS. This approach to detect them could allow definition of immunodominant T cell epitopes in individual MS patients, and thereby enable further development towards specific immunotherapy.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009185 Myelin Proteins MYELIN-specific proteins that play a structural or regulatory role in the genesis and maintenance of the lamellar MYELIN SHEATH structure. Myelin Protein,Protein, Myelin,Proteins, Myelin
D002555 Cerebrospinal Fluid A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. Cerebro Spinal Fluid,Cerebro Spinal Fluids,Cerebrospinal Fluids,Fluid, Cerebro Spinal,Fluid, Cerebrospinal,Fluids, Cerebro Spinal,Fluids, Cerebrospinal,Spinal Fluid, Cerebro,Spinal Fluids, Cerebro
D004676 Myelin Basic Protein An abundant cytosolic protein that plays a critical role in the structure of multilamellar myelin. Myelin basic protein binds to the cytosolic sides of myelin cell membranes and causes a tight adhesion between opposing cell membranes. Golli-MBP1 Protein,Golli-MBP2 Protein,HOG5 Protein,HOG7 Protein,MBP1 Protein,MBP2 Protein,MBP3 Protein,MBP4 Protein,Myelin Basic Protein, 17.2 kDa Isoform,Myelin Basic Protein, 18.5 kDa Isoform,Myelin Basic Protein, 20.2 kDa Isoform,Myelin Basic Protein, 21.5 kDa Isoform,Myelin Basic Protein, Isoform 1,Myelin Basic Protein, Isoform 2,Myelin Basic Protein, Isoform 3,Myelin Basic Protein, Isoform 4,Myelin Basic Protein, Isoform 5,Myelin Basic Protein, Isoform 6,Myelin Basic Protein, Isoform 7,Golli MBP1 Protein,Golli MBP2 Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001324 Autoantigens Endogenous tissue constituents with the ability to interact with AUTOANTIBODIES and cause an immune response. Autoantigen,Autologous Antigen,Autologous Antigens,Self-Antigen,Self-Antigens,Antigen, Autologous,Antigens, Autologous,Self Antigen,Self Antigens

Related Publications

T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
HIV antigen-reactive T cells detected by antigen-induced interferon gamma secretion.
February 1994, AIDS research and human retroviruses,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Listeria monocytogenes-induced gamma interferon secretion by intestinal intraepithelial gamma/delta T lymphocytes.
May 1993, Infection and immunity,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Effect of interferon gamma on T lymphocytes from patients with multiple sclerosis.
January 1995, Multiple sclerosis (Houndmills, Basingstoke, England),
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
March 1999, Acta neurologica Belgica,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Autoreactive T cells in multiple sclerosis.
January 1992, International reviews of immunology,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis.
March 1998, Lancet (London, England),
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Soluble class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis.
January 1993, European neurology,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
February 1999, Annals of neurology,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?
March 2002, Journal of neuroimmunology,
T Olsson, and W W Zhi, and B Höjeberg, and V Kostulas, and Y P Jiang, and G Anderson, and H P Ekre, and H Link
Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis.
June 1997, Multiple sclerosis (Houndmills, Basingstoke, England),
Copied contents to your clipboard!